Based on 7 analysts giving stock ratings to Q32 Bio Inc in the past month.
In the current month, QTTB has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. QTTB average Analyst price target in the last month is 39.429.
Based on analysts' estimates, QTTB EPS is projected to reach -0.302 in FY2026Q4, following reported EPS of -0.262 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.26, while Q32 Bio IncQTTB's earnings per share (EPS) for the previous quarter was USD -0.44. EPS for the next quarter is expected at USD -0.30.